Review 2023 · 12 atıf

The effects of<i>Berberis vulgaris</i>L. and<i>Berberis aristata</i>L. in metabolic syndrome patients: a systematic and meta-analysis study

Roshanravan, Babak, Yousefizadeh, Shahnaz, Yildirim, Betul Apaydin, Farkhondeh, Tahereh, Amirabadizadeh, Alireza, Ashrafizadeh, Milad, Talebi, Marjan, Samarghandian, Saeed

Özet

Introduction This meta-analysis study assessed the effects ofBerberis vulgarisL. andBerberis aristataL. in patients with metabolic syndrome Methods Data were analysed through "random-effects meta-regression" performance Results The findings indicated that LDL was 0.68 and 2.92 lower in theB. vulgarisL. andB. aristataL.-treated groups versus the controls. The HDL was 0.71-fold higher in theB. aristataL.-treated group versus the controls. The total-cholesterol levels were 1.02 and 2.25 folds lower in theB. vulgarisL. andB. aristataL.-treated groups versus the matched control groups. The triglyceride levels were 1.35 and 1.16-fold lower in theB. vulgarisL. andB. aristataL.-treated groups versus the controls. Glucose was 0.96 and 0.54 folds lower in theB. vulgarisL. andB. aristataL.-treated groups versus the control groups, respectively Conclusion B. vulgarisL. andB. aristataL. have beneficial effects in patients with metabolic syndrome.

Anahtar Kelimeler

Berberis aristataL Berberis vulgarisL metabolic syndrome BERBERIS-ARISTATA/SILYBUM-MARIANUM LIPID PROFILE FIXED COMBINATION DOUBLE-BLIND ASSOCIATION STATINS AGENTS

WoS Kategorileri

Biochemistry & Molecular Biology Biophysics Endocrinology & Metabolism Physiology

Sürdürülebilir Kalkınma Amaçları

Sağlık ve Kaliteli Yaşam

Künye

Dergi: ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Yıl: 2023
Cilt: 129
Sayı: 2
Sayfa: 393-404
ISSN: 1381-3455
eISSN: 1744-4160
DOI: 10.1080/13813455.2020.1828482
WoS UID: WOS:000579134000001

Yayını aç (DOI)